nejm tirzepatide osa #Mounjaro/#zepbound (tirzepatide) for obesity complicated by sleep apnea trials presented at #ADA2024 and published in @nejm1️⃣ Participants who were not receiving treatment with positive airway Obesity and obstructive sleep apnoea:
Description
PlexusDx explains how these medications work together, potential interactions, and how compounded tirzepatide offers a personalized alternative
Experts say more education and awareness are needed.
Notable Articles of 2024: FLOW trial In patients with type 2 diabetes and chronic kidney disease, weekly semaglutide significantly reduced risks of major kidney events, cardiovascular events, and death from any cause while slowing loss of kidney function.
New research suggests that GLP-1 medications may lower the risk of age-related macular degeneration, the leading cause of vision loss in older US adults.
Undeniably, this is an exciting time for the obesity market as it is facing a major inflection point
But emerging research suggests amylin agonists might become the next big thing.
